EUVIMED · CrossrefJournal
British Journal of Haematology
ISSN 0007-1048 · Wiley
Latest articles
Nodular immunoglobulin‐associated pulmonary amyloidosis with extensive osseous metaplasia
CAR‐T cells in first relapse of paediatric Down syndrome B‐cell acute lymphoblastic leukaemia: Oncologist perspectives
Response to ‘Sustained MRD negativity or guaranteed survival time in multiple myeloma?’
Response to Vincenzi et al. on: ‘Real‐world treatment burden of BV ‐based frontline regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma’
VEXAS syndrome with UBA1 p. Ser56Phe in a 46, XX woman
Long‐read nanopore sequencing: A rapid and highly accurate approach for IGHV gene analysis in chronic lymphocytic leukaemia
An unintended consequence of a FLT3 inhibitor
Even a worm may turn: Opportunistic strongyloides hyperinfection
Long‐term relapse dynamics and relative survival after autologous haematopoietic stem cell transplantation for mantle cell lymphoma: 25‐year follow‐up of the Nordic MCL2 and MCL3 trials
Interpreting thrombin and reptilase times: Beyond heparin contamination
Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma
Haematological malignancies in paediatric and adolescents or young adults patients with Li‐Fraumeni syndrome: Retrospective multi‐institutional case series
Estimated pulse wave velocity in ET and PV : A biologically plausible risk marker awaiting prospective validation
Complex karyotype and non‐ BTK driver mutations associated with BTK inhibitor resistance in chronic lymphocytic leukaemia
Practical Transfusion Medicine7th Edition Edited by Michael F.Murphy, Nancy M.Dunbar and Erica M.Wood, Wiley. 2026. ISBN‐10: 1394291965
Spatial and transcriptomic analyses reveal the adverse prognostic impact of regulatory T cells in follicular lymphoma treated with rituximab–lenalidomide
A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study
Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease
CD20 antigen loss post‐venetoclax/anti‐ CD20 therapy in chronic lymphocytic leukaemia: Frequency, characteristics and potential therapeutic implications
Correction to ‘Risk factors and reasons for switching from front‐line therapy in the Italian chronic myeloid leukaemia network: A cohort study’
Caregiver support in patients with plasma cell dyscrasias: A novel single‐item pilot measure of caregiver availability: Results from a survey of >1000 patients
Clinical phenotypes, autoimmunity and outcomes in Rosai–Dorfman disease: An international multicentre cohort study
Indole‐3‐lactic acid ameliorates thrombocytopenia in primary immune thrombocytopenia by modulating the differentiation of Th17 and Tregs
Comment on ‘Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6 ‐related thrombocytopenia’
Response to: Comment on ‘Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6 ‐related thrombocytopenia’
NPM1 ‐mutated AML : One entity, multiple layers of heterogeneity
Rare variants of NPM1 mutations share a similar molecular background to the common NPM1 type A variant and are associated with similar survival in adults with acute myeloid leukaemia
Orelabrutinib plus R‐ CHOP in patients with newly diagnosed non‐ GCB double‐expressor DLBCL : A single‐arm, phase II study
Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ ALL ) and lymphoblastic lymphoma (T‐ LBL )
Phagocytosis activity is retained by JMML macrophages and increased by CD47 inhibition
Volumes
2026 · 7722025 · 6272024 · 7132023 · 6652022 · 6782021 · 7182020 · 8622019 · 7212018 · 5762017 · 5382016 · 6082015 · 5182014 · 5112013 · 4992012 · 4672011 · 4672010 · 4932009 · 4992008 · 5582007 · 4942006 · 5452005 · 5612004 · 5452003 · 7182002 · 7812001 · 7402000 · 8741999 · 7821998 · 6901997 · 6111996 · 5851995 · 5871994 · 5671993 · 4511992 · 4111991 · 4101990 · 4361989 · 4001988 · 3631987 · 432
EUVIMED